Post-Varicella Acute Inflammatory Demyelinating Polyradiculoneuropathy in a 51-year old Filipino Male: A Case Report

INTRODUCTION

Vricella-zoster virus is the etiologic agent of varicella (primary infection) and herpes zoster (reactivation of latent infection). It is commonly observed among school-aged children. In tropical climates, more cases are reported among adults. Although varicella is most often a relatively benign and self-limited childhood illness, the disease can be associated with a variety of serious and potentially lethal complications in both immunocompetent and immunocompromised persons.(1, 2)

The incidence of neurologic complications associated with varicella is estimated to be 1–3 per 10,000 cases. The rarer of these complications is GuillanBarre syndrome (GBS) or acute inflammatory demyelinating polydradiculoneuropathy (AIDP), with less than 50 cases in reported literature. (1-4)

We report a case of a 51 year-old Filipino male who presented with bilateral lower extremity weakness and numbness indicative of a demyelinating polyradiculoneuropathy two weeks after a primary varicella infection.

 

PATIENT INFORMATION

Our patient is a 51-year-old male admitted due to progressive numbness and weakness of the lower extremities.

In early March 2015, he had intermittent undocumented fever, followed shortly after by the appearance of vesicular, pruritic, non-painful rashes on his upper back, which eventually spread to his face, chest and extremities. Interval history showed lysis of the fever after three days but there was worsening of the rashes.

Two weeks after the appearance of the rashes, the patient began to experience numbness on both his soles and palms. He also noted difficulty in walking and making precise steps as he easily lost balance. He preferred to stay seated but was still able to ambulate and maintain a standing position with assistance. No weakness of extremities was reported at this time.

He sought consult at a clinic and was assessed with a non-specific nerve problem. No work-up was done. He was given Vitamin B complex, which did not afford relief of his symptoms. Four days later, he noted progression of the numbness from his soles to the lower third of his distal legs. This was now accompanied by weakness of his distal legs, feet and handgrip. He could no longer ambulate and maintain a standing position. He also experienced dull pain on the palmar area of both hands, extending to his forearms, upper arms and shoulders, most prominent whenever he tried to reach out for an object. No disturbances in bladder or bowel functions, slurring of speech, facial asymmetry, double vision, or dysphagia were noted.He has history of hypertension and ismaintained on losartan 40mg/tab 1 tab BID. He also has a family history of hypertension and diabetes. No other family members presented with symptoms similar to the patient. Fasting blood sugar of this patient showed normal result at 98.10 mg/dL (NV <126mg/dL).

 

CLINICAL FINDINGS

Physical and neurological examination showed multiple generalized hyperpigmented scars (Fig. 2). He had intact cognition and cranial nerve functions. On tandem gait, he had a tendency to fall on either side. Manual motor testing revealed a score of 4/5 for both wrist extensors and flexors, finger abductors and adductors, as well thumb flexors and extensors of both upper extremites. The rest of the upper extremity muscle groups were scored 5/5. For both lower extremities, a score of 4/5 was given to plantar flexors and dorsiflexors, as well as the plantar flexors and dorsiflexors of both big toes. He had no biceps, triceps, and brachioradialis reflex. He was hyporeflexive on both knees and ankles. On sensory examination he had a 20% sensory deficit to light touch and pinprick in both lower extremities, he had impaired vibration sense and position sense in both upper and lower extremities. We noted mechanical and touch allodynia on both lower extremites, distal more than the proximal. He tested positive on Romberg’s test and was ataxic on ambulation. He had a wide-based stance and gait, irregular stepping, with a tendency to stagger, and inappropriate timing of foot placement. There was no Babinski reflex.

 

TIMELINE

Text Box: Asymptomatic. Text Box: March 1-28, 2015. Text Box: Undocumented fever, vesicular, pruritic, non-painful rashes, difficulty in ambulation, weakness numbness of the upper and lower extremities. Text Box: April 01, 2015. Text Box: Intact cognition and cranial nerve functions, tendency to fall on either side on tandem gait. Manual motor testing 4/5 for both wrist extensors and flexors, finger abductors and adductors, as well thumb flexors and extensors of both upper extremites, plantar flexors and dorsiflexors, as well as the plantar flexors and dorsiflexors of both big toes. Areflexic upper extremities and hyporeflexive lower extremities. 20% sensory deficit to light touch and pinprick in both lower extremities, impaired vibration sense and position sense in both upper and lower extremities. Mechanical and touch allodynia on both lower extremites, distal more than the proximal, positive on Romberg’s test and was ataxic on ambulation. He had a wide-based stance and gait, irregular stepping, with a tendency to stagger, and inappropriate timing of foot placement. There was no Babinski reflex.

 

Text Box: April 2, 2015. Text Box: CSF protein 69mg/dl (NV 15 to 45 mg/dl). CSF Varicella virus IgG was at 1.8 mIU/ml (NV 1.3 mIU/ml) IgM was at 1 mIU/ml (NV 0.9 mIU/ml) indicative of a past varicella infection. Nerve conduction velocity studies of all extremities and the face showed delayed latencies, prolonged conduction velocities, temporal wave dispersion, proximal partial conduction block, and prolonged or absent F-responses. Text Box: April 2, 2015. Text Box: Given Gabapentin 100mg/cap 1 cap TID for the allodynia. Text Box: June 2015. Text Box: Asymptomatic.

Figure 1. Course of the illness.

 

DIAGNOSTIC ASSESSMENT

Lumbar puncture and CSF analysis of this patient showed normal opening and closing pressure, as well as CSF glucose levels. There was elevation of CSF protein at 69mg/dl (NV 15 to 45 mg/dl). CSF Varicella virus IgG was at 1.8 mIU/ml (NV 1.3 mIU/ml)IgM was at 1 mIU/ml (NV 0.9 mIU/ml) indicative of a past varicella infection.Nerve conduction velocity studies of all extremities and the face showeddelayed latencies, prolonged conduction velocities, temporal wave dispersion, proximal partial conduction block, and prolonged or absent F-responses (Fig. 3, Table 1).

There is electrophysiologic evidence of diffuse sensorimotor polyneuropathy, demyelinating in nature which indicates presence of an acute inflammatory demyelinating polyneuropathy.

 

THERAPEUTIC INTERVENTION

The patient was closely monitored withspontaneousgradual improvement of symptoms while admitted. Gabapentin 100mg/cap 1 cap TID was given to address his allodynia.

 

FOLLOW-UP AND OUTCOMES

He was completely asymptomatic when he was last seen 2 months after discharge on June 2015.

 

DISCUSSION

Varicella zoster infection may cause several neurological complications like myelitis, aspectic meningitis, meningoencephalitis, ventriculitis, herpes zoster ophthalmicus and AIDP. (5) Cell-mediated immunity and other degrees of immunosuppression are known to follow viral infections. There is depression of tuberculin reactivity in varicella infectionsuggesting the role of immunosuppression as a contributing factor in triggering an autoimmune disease of the peripheral nervous system. (6, 7) It is possible that viral infections may reduce suppressor T cell activity thereby leading to proliferation of few T and B lymphocytes, which are normally present in humans and recognize nervous system antigen. (8) Reduction of the suppressor T cell subpopulation in patients with AIDPis consistent with this hypothesis. AIDP is a post-infective immune-mediated phenomenon, which causes rapidly progressive, diffuse proximal and distal weakness of the limbs, accompanied by sensory loss and areflexia. (9)

Symptoms of involvement of the nervous system following varicella develop between the fifth and twentieth day after the appearance of the rash, usually in the first half of the second week. (10) Antibodies positive to gangliosides can be attributed to poor recovery or rapidly reversible weakenss. (11) This is can be considered as the limitation of this study as this CSF examination was not determined.

The clinical picture and nerve conduction velocity studies result of this patient is suggestive of a demyelinating type of sensorimotor polyneuropathy. Likewise, the appearance of vesiculopapular rashes following a history of fever is highly suggestive of a primary varicella infection.

  1. Anne G. Varicella and herpes zoster: Clinical disease and complications. Herpes. 2006; 13:2A-7A.
  2. GnannJr JW. Varicella-zoster virus: atypical presentations and unusual complications. The Journal of infectious diseases. 2002 Oct 15;186(Supplement_1):S91-8.
  3. Cresswell F, Eadie J, Longley N, Macallan D. Severe Guillain–Barré syndrome following primary infection with varicella zoster virus in an adult. International Journal of Infectious Diseases. 2010 Feb 28; 14(2):e161-3.
  4. Guess HA, Broughton DD, Melton L3, Kurland LT. Population-based studies of varicella complications. Pediatrics. 1986 Oct 1; 78(4):723-7.
  5. Ranga S, Avati AV. Primary varicella zoster infection presenting as Guillain-Barre-like syndrome. A case report and review of the literature.
  6. Starr S, BERKOVICH S. The depression of tuberculin reactivity during chickenpox. Pediatrics. 1964 May 1; 33(5):769-72.
  7. Lisak RP, Mitchell M, Zweiman B, Orrechio E, Asbury AK. Guillain‐Barré syndrome and Hodgkin's disease: Three cases with immunological studies. Annals of neurology. 1977 Jan 1; 1(1):72-8.
  8. Winer JB, Greenwood RJ, Hughes RA, Perkin GD, Healy MJ. Prognosis in Guillain-Barrésyndrome. The Lancet. 1985 May 25; 325(8439):1202-3.
  9. Hughes RA, Aslan S, Gray IA. Lymphocyte subpopulations and suppressor cell activity in acute polyradiculoneuritis (Guillain-Barré syndrome). Clinical and experimental immunology. 1983 Mar;51(3):448.
  10. McKendall RR, Klawans HL. Nervous system complications of varicella-zoster virus. Handbook of clinical neurology. 1978; 34:161-83.
  11. Rajabally YA, Uncini A. Outcome and its predictors in Guillain–Barré syndrome. J NeurolNeurosurg Psychiatry. 2012 Jan 1: jnnp-2011.

 

Figure. 2. Multiple generalized hyperpigmented lesions over the face and back.

 


Figure 3. Delayed latency, temporal wave dispersion seen on the left tibialmotor nervenerve study.

 

Table 1. A summary of the nerve conduction velocity abnormalities in this patient


Nerve Conduction Velocities Abnormalities

 

Motor

Sensory

Delayed latencies or absent response

Bilateral ulnar nerves

Bilateral median nerves

Peroneal nerves

Tibial nerves

Bilateral median nerves

Bilateral ulnar nerves

Bilateral sural nerves

Bilateral superficial peroneal

Prolonged conduction velocities or absent response

Bilateral median nerves

Bilateral ulnar nerves

Bilateral peroneal nerves

Bilateral tibial nerves

Bilateral median nerves

Bilateral ulnar nerves

Bilateral peroneal nerve

Bilateral sural nerves

Temporal dispersion

Bilateral median nerves

Bilateral ulnar nerves

Bilateral peroneal nerves

tibial nerves

 

Partial conduction block

Bilateral median nerves

Bilateral ulnar nerves

Bilateral peroneal nerves

Bilateral tibial nerves

 

Prolonged or absent F wave response

Tibial nerves

Absent H-reflex response

Tibial nerves

 

CC BY: Open Access Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/